The KHENEREXT Study

Clinical trial NCT04604548 · COMPLETED

Trial details

NCT number: NCT04604548
Sponsor: Khondrion BV
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mitochondrial Diseases Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation Maternally Inherited Diabetes and Deafness (MIDD)Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke Like Episodes (MELAS)Chronic Progressive External Ophthalmoplegia (CPEO)

Start date: 2021-08-09
Primary completion: 2023-06-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.